Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2024.08.06.606841

Performance of low-threshold, population replacement gene drives in cage populations of the yellow fever mosquito, Aedes aegypti

Speth, Z.·Rehard, D.·Norton, P.·Franz, A. W. E.
View original source ↗Export metadata ↓

Abstract

Aedes aegypti is the predominant vector for arboviruses including dengue, Zika, and chikungunya viruses, which infect over 100 million people annually. Mosquito population replacement strategies in which pathogen-susceptible mosquitoes in the field are replaced by laboratory-engineered pathogen-resistant strains are novel genetic control measures to inhibit the spread of malaria or arboviral diseases in endemic regions. To suppress arbovirus transmission following this approach, a mosquito strain needs to be transgenically modified to express an antiviral effector molecule which is linked to a gene drive (GD) system to both inhibit viral replication in the mosquito and drive the engineered resistance trait throughout a wild-type population. As a proof-of-concept, we tested the performance of two single locus CRISPR-Cas9 based GD for Ae. aegypti population replacement in small cage populations over 12 generations. Starting from a low release threshold of 1:9 GD bearing males, we observed two GD constructs in which Cas9 was expressed from different promoters increase in frequency in all discrete, non-overlapping cage populations. By generation 12, 56-79% of mosquitoes in six cage populations had at least one GD copy. The allele frequencies of the GD increased from <5% at release to >50% by G7 post-release for the nanos-driven Cas9 GD and by G10 in populations harboring the zpg-driven Cas9 GD. Insertion and deletion mutation (indel) frequency was measured for each discrete generation in pooled samples from the six populations harboring GD. We found that populations with Cas9 expression under control of the nanos-promoter accumulated gene drive blocking indels (GDBI) at more than twice the rate of populations harboring the zpg-promoter driven GD. Both GD produced de novo mutations at similar rates, with a difference in selection being the primary cause of greater indel accrual in the nanos-driven GD populations. Our results demonstrate that two single-locus, CRISPR-Cas9-based homing GD located at an intergenic locus exhibit continuous super-Mendelian inheritance in populations of Ae. aegypti. We further analyze the effects of fitness cost on the stability of low-threshold CRISPR/Cas9 based GD in populations of Ae. aegypti. This study demonstrates the feasibility of low-threshold, single-locus Cas9 gene drives for Ae. aegypti population replacement.

Explore related subjects

geneticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Speth, Z., Rehard, D., Norton, P., Franz, A. W. E.. 2024-08-08. Performance of low-threshold, population replacement gene drives in cage populations of the yellow fever mosquito, Aedes aegypti. https://doi.org/10.1101/2024.08.06.606841

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Large language model-based bibliometric evaluation of population descriptors in human genetics

As the use of population descriptors such as race, ethnicity, and ancestry have become increasingly common in modern genetics research, there have been growing calls to critically examine their use. Most notably, in 2023, the National Academies of Science, Engineering, and Medicine (NASEM) published a report titled Using Population Descriptors in Genetics and Genomics Research: A New Framework for an Evolving Field, which included eight specific and actionable recommendations for researchers to implement the ethical and accurate use of population descriptors in genetic research. Here, we use the 2023 NASEM report as a benchmark to analyze the use of population descriptors in genome-wide association studies (GWAS). We develop a general toolkit for large language model-based bibliometrics, operationalize the report's recommendations into an evaluation framework, and apply this framework to evaluate all 4,007 papers from the GWAS Catalog published between 2007 and 2025 with full text available on PubMedCentral. We find significant improvements in adherence to NASEM report recommendations over time. However, most improvements predate the publication of the NASEM report itself, suggesting the report functioned primarily as a synthesis of existing best practices rather than a catalyst for change. We conclude by highlighting opportunities for growth in the field of human genetics.

genetics↗
bioRxiv2026

Mitigating biases of rescaling in forward-in-time population genetic simulations

Forward-in-time population genetic simulations are widely used in evolutionary analyses, but simulating large populations and long genomic regions remains computationally demanding. To reduce this cost, parameter rescaling is widely employed, in which the original evolutionary process is approximated by one with a smaller population size and fewer generations. Recently, several studies using the SLiM simulator have raised concerns about the accuracy of this rescaling approach. In this study, we show that many of the biases reported in these studies can be mitigated by using a different simulation algorithm. These results reveal that the accuracy of parameter rescaling depends on how well the simulation algorithm preserves diffusion-limit properties under rescaling.

genetics↗
bioRxiv2026

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗